Abstract:Abstract Nasopharyngeal carcinoma (NPC) has its highest incidence in southern China and Southeast Asia. In order to obtain deeper insights into the molecular mechanism of NPC tumorigenesis, we performed genome expression profiling combined with computerized pathway analyses on 18 NPC tissues and 18 age-matched tissues of non-cancerous nasopharyngeal mucosa from individuals in the endemic area, Guangdong province, China, between Dec 2007 and Oct 2010. Gene expression profiling was performed using an Agilent gene expression kit and Agilent 4×44K microarray gene chips. One-way analysis of variance was used to identify the genes differentially expressed between cancer and non-cancerous tissues. Genes with a false discovery rate of less than 0.001 and a fold-change larger than 2 or less than 0.5 were selected for in silico network mapping combined with pathway analysis using GeneGo software. Pathways were prioritized based on the gene enrichment analysis. The genes’ connectivity was also integrated to identify the regulatory hotspots in the key pathways. Genes within or surrounding these hotspots constitute potential therapeutic targets. Genes previously known to be up-regulated in NPC that were detected in our study included CCND1, CDKN1A, STAT1, BCL2A1, SGK1, RAI14, FOXM1, EPHB2, PMAIP1, COL1A1, GADD45A, ICAM1, FANC1, ZWINT, LAMB3, CKAP4, ISG15, and MMP3; known down-regulated genes included ATM and INPP5D. However, what was of interest was the identification of a series of previously unrecognized genes: those up-regulated more than 10-fold included MMP1, HOXC8, KREMEN2, and HOXA1, and those down-regulated more than 10-fold included LTF, C7, SHISA3, SKLC26A7, and C16orf89. Although the deregulated pathways in NPC encompass many cytological functions, pathway analysis has been helpful in ranking a series of the most significant deregulated pathways, which include ECM remodeling pathways; alternative complement pathway; plasmin signaling pathway; the TGF, WNT, and cytoskeletal remodeling pathways; leukocyte chemotaxis pathway; and the BAFF and PLAU signaling pathways. Results will be presented on key genetic changes within these pathways that have been verified by biologically. In conclusion, we are beginning to recognize key genes and pathways, prioritized by pathway analysis, that appear likely to identify possible novel mechanisms of NPC tumorigenesis. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 57. doi:10.1158/1538-7445.AM2011-57

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

Prognosis-related Molecular Subtyping of Nasopharyngeal Carcinoma

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma

Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma

Abstract 57: Integrating Transcriptome Profiling and in Silico Pathway Analysis Toward Reduction of Therapeutic Dimensionality in Nasopharyngeal Carcinoma

Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses

Prognostic Implications of a Molecular Classifier Derived from Whole‐exome Sequencing in Nasopharyngeal Carcinoma

Transcriptional Patterns, Biomarkers and Pathways Characterizing Nasopharyngeal Carcinoma of Southern China

Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution

Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling

Multi-Modality Imaging To Determine The Cellular Heterogeneity Of Nasopharyngeal Carcinoma Components

Neoantigen landscape in metastatic nasopharyngeal carcinoma

Gene Expression Profile Changes and Possible Molecular Subtypes in Differentiated-Type Nonkeratinizing Nasopharyngeal Carcinoma

Identifying key genes and small molecule compounds for nasopharyngeal carcinoma by various bioinformatic analysis

Primary and Orthotopic Murine Models of Nasopharyngeal Carcinoma Reveal Molecular Mechanisms Underlying its Malignant Progression

Key radioresistance regulation models and marker genes identified by integrated transcriptome analysis in nasopharyngeal carcinoma

Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways